Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Surfactant therapy of respiratory distress syndrome

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Orbital cysticercosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Palytoksinforgiftning relateret til saltvandsakvarie

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Presence of SARS-CoV-2 in semen and the impact of COVID-19 on the male reproductive system

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Flying fattens and swimming slims - the secret of the mermaid

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Behandling af mandlig infertilitet

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Severe foetal anaemia caused by undetected alloimmunisation in a RhD-positive pregnant woman

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aerosol generation by respiratory support of neonates may be low

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Fatal case of hospital-acquired hypernatraemia in a neonate: lessons learned from a tragic error

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Bronchopulmonary dysplasia predicted at birth by artificial intelligence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

This review gives a summary of the development of a method to measure lung surfactant on gastric aspirate at birth in premature infants with the purpose to threat respiratory distress syndrome early with targeted surfactant. Machine learning was used to create the algorithm, and a point-of-care spectrometer was constructed for use in the delivery room. The sensitivity was 91% and specificity 79% in a clinical trial. The same method was used to measure surfactant in tracheal fluid in patients with COVID-19 since lung surfactant may be diminished in these patients.

Bidragets oversatte titelSurfactant therapy of respiratory distress syndrome
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind183
Udgave nummer44
ISSN0041-5782
StatusUdgivet - 1 nov. 2021

    Forskningsområder

  • COVID-19, Humans, Infant, Infant, Newborn, Pulmonary Surfactants/therapeutic use, Respiratory Distress Syndrome, Newborn/drug therapy, SARS-CoV-2, Surface-Active Agents/therapeutic use

ID: 69076179